Perfluoroalkyl and polyfluoroalkyl substances (PFASs) crossing the blood-cerebrospinal fluid barrier: Their occurrence in human cerebrospinal fluid

By Wei Hu, Ming-Yan Zhang, Liang-Ying Liu, Zi-Feng Zhang, and Ying Guo
J Hazard Mater
September 15, 2022
DOI: 10.1016/j.jhazmat.2022.130003

Data remain scarce regarding the occurrence of per- and polyfluoroalkyl substances (PFASs) in the human brain for better understanding the cerebral disorders. In this study, we measured the concentrations and profiles of 26 traditional and emerging PFASs in cerebrospinal fluid (CSF), which is a preferred matrix to monitor pollutants in the human brain. Our results indicated perﬂuorooctanesulfonate (PFOS), perﬂuorooctanoic acid (PFOA), perﬂuorohexanesulfonate (PFHxS) and n-methylperﬂuorooctanesulfonamidoacetic acid were the most frequently detected congeners (detection frequency >90%). As the predominant congeners, PFOA and PFOS contributed 27.7% and 14.5% of the total amount of PFASs (ΣPFASs), with respective mean concentration of 221 and 115 pg mL^-1. In addition, the concentrations of ΣPFASs in CSF of males were generally higher than those of females, which may be related to the different half-lives of PFASs in different sexes. Interestingly, the concentrations of ΣPFASs and several individual congeners (e.g., perﬂuorohexanoic acid, perﬂuorodecanoic acid, perﬂuorononanoic acid, PFHxS and PFOS) increased with age. The highest concentration of ΣPFASs was found in the elderly compared with other age groups, which may be due to the decreased CSF output as age increased. Our data are valuable for further studies regarding the toxic effects of PFASs on the human brain.

View on PubMed